Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) Investor Files Lawsuit to Stop Takeover
A lawsuit was filed for investors in NASDAQ:AMLN shares to stop the proposed takeover of Amylin Pharmaceuticals, Inc. and other NASDAQ:AMLN stockholders should contact the Shareholders Foundation.
View full press release